Antioxidant nutrient supplementation and brachial reactivity in patients with coronary artery disease

Ronald McKechnie1, Melvyn Rubenfire, Lori Mosca

  • 1Department of Internal Medicine, Division of Cardiology, University of Michigan Medical Center, Ann Arbor, MI, USA.

Insights

Combined antioxidant supplements did not improve endothelial function in patients with coronary artery disease (CAD), despite increasing plasma antioxidant levels. Further research is needed to evaluate individual antioxidant effects on cardiovascular health.

Area of Science:

  • Cardiovascular Research
  • Nutritional Science
  • Clinical Trials

Background:

  • Epidemiologic studies suggest a link between antioxidant intake and coronary artery disease (CAD).
  • Clinical trial results on antioxidant supplementation for CAD have been inconsistent.
  • The impact of combined antioxidants on endothelial function and LDL oxidation in CAD patients requires further investigation.

Purpose of the Study:

  • To evaluate the effect of combined antioxidant supplementation on endothelial function in patients with established CAD.
  • To assess the correlation between changes in endothelial function and low-density lipoprotein cholesterol (LDLC) oxidation.
  • To compare the efficacy of two different dosages of combined antioxidant supplementation against a placebo.

Main Methods:

  • A 12-week, double-blind, placebo-controlled trial involving 18 patients with established CAD.
  • Randomization to placebo or two different doses of combined antioxidant supplements (vitamins E, C, and beta-carotene).
  • Assessment of endothelial function via brachial artery diameter changes during reactive hyperemia; LDL oxidation measured by lag phase.

Main Results:

  • Significant increases in plasma alpha-tocopherol, vitamin C, and beta-carotene were observed in the antioxidant groups compared to placebo.
  • Both groups showed improved LDL oxidation lag phase, with a trend towards greater improvement in the treatment group (P=.06).
  • No statistically significant improvement in brachial artery reactivity was found in the treatment group; the placebo group showed significant improvement (P<.05).

Conclusions:

  • Combined antioxidant supplementation did not significantly improve endothelial function in patients with CAD.
  • Despite increased plasma antioxidant levels and improved LDL oxidation lag phase, brachial reactivity was not significantly altered.
  • Larger trials evaluating individual dietary antioxidants are recommended to clarify their role in cardiovascular health.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Acute Coronary Syndrome V: Nursing Management01:26

Acute Coronary Syndrome V: Nursing Management

Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...